Latest Funding News

Citigroup Global Markets Australia has declared the record and ex-dividend dates for the estimated fully franked dividend on BHP CitiFirst Self-Funding Instalment warrants, triggering reductions in outstanding loan amounts for warrant holders.

Nexalis Therapeutics has initiated its Phase 1 trial for IRX-616a, an inhaled cannabidiol treatment aimed at panic disorder, marking a significant step in developing rapid-onset anxiety therapies.

Vintage Energy has secured an extension on its $10 million loan facility with PURE Asset Management, providing financial flexibility to advance drilling and joint venture plans at its Southern Flank gas projects.

ClearVue Technologies has locked in a $3 million structured funding facility tied to its R&D tax credits, aiming to accelerate certification milestones and commercial deployment without diluting shareholders.

OD6 Metals has secured an exclusive option to acquire the Quinn Fluorspar Project in Nevada, boasting ultra high-grade deposits critical to US supply chains. The move complements its rare earth and copper assets, backed by a $3.4 million capital raise.

Cosmos Exploration Limited has been reinstated to ASX quotation following the exercise of an Option Agreement and a Placement, ending its trading suspension.

AKORA Resources has secured a 25-year mining permit for its high-grade Bekisopa iron ore project in Madagascar, marking a pivotal step from exploration to development and unlocking new financing and partnership opportunities.

The Calmer Co. International Limited’s Fiji subsidiary has secured a FJ$548k non-repayable grant to expand ready-to-drink production and upgrade supply chain infrastructure, accelerating its growth without diluting shareholder equity.

Horizon Gold Limited has raised A$30 million through a placement and entitlement offer to accelerate exploration and advance the feasibility study at its Gum Creek Gold Project in Western Australia.

Great Southern Mining has commenced co-funded diamond drilling at two promising Western Australian targets, aiming to unlock platinum group elements and high-grade gold mineralisation.

PYC Therapeutics has successfully closed its retail entitlement offer, raising approximately $47 million at $1.50 per new share with a 40% take-up rate. New shares are set to begin trading on the ASX from 9 March 2026.

Brightstar Resources has completed a US$120 million senior secured bond issue, complementing a recent A$193 million equity raise, to fully fund its Goldfields Project and advance the Sandstone Project towards final investment decision.